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Abstract
Objective—To assess the impact of health care access and socioeconomic determinants on Pap
smear screening in Latin America.
Methods—Individual-level data was collected from the Demographic and Health Surveys in
Bolivia, Brazil, Dominican Republic, Ecuador, Guatemala, Nicaragua, Peru, and Trinidad and
Tobago between 1987 and 2008. Multivariate logistic regression analyses were used to identify
socioeconomic and health care determinants of two outcomes: knowledge of Pap smears and
recent Pap smear screening.
Results—In all countries, the proportion of women with a recent Pap smear screening remained
below 55%. Key determinants of knowledge of Pap smears were age, education, and recent
doctor’s visit. For recent Pap smear screening, key determinants were wealth and recent doctor’s
visit. Women were between 1.47 and 3.44 times more likely to have received a recent Pap smear if
they had a recent doctor’s visit. Even the poorest women with a recent doctor’s visit were more
likely to screen than the richest women without a recent visit.
Conclusions—These data suggest that visiting a doctor is an important determinant of cervical
cancer screening in Latin America. Because screening may coincide with other medical visits,
physicians could effectively encourage screening.
Keywords
Uterine cervical neoplasms; vaginal smears; mass screening; Bolivia; Brazil; Dominican Republic;
Ecuador; Guatemala; Nicaragua; Peru; Trinidad and Tobago; Latin America
The burden of cervical cancer is especially high in Latin America (1), now ranking as the
second most common cause of cancer among women in the region. In 2008, incidence in
Latin America was four times higher and mortality five times higher than in North America
(with incidence and mortality rates of 25 and 11 versus 6 and 2 cases per 100 000
respectively) (2). Historically, prevention efforts largely focused on Pap smears. When
conducted effectively, implementation of this type of screening has coincided with
significant declines in cervical cancer incidence and mortality. For example, in Iceland,
where a cost-effective nationwide screening program was initiated in 1964, up-to-date
screening coverage had reached 80% of women 25–69 years old by 1990, leading to a
Send correspondence to: Samir Soneji, samir.soneji@dartmouth.edu.
Conflict of interest. None.
NIH Public Access
Author Manuscript
Rev Panam Salud Publica. Author manuscript; available in PMC 2013 July 26.
Published in final edited form as:













reduction in cervical cancer incidence and mortality of more than 80% (3, 4). In contrast,
little progress has been observed in Latin America, where screening rates remain
consistently low, even in countries with national screening programs (5–7).
Collective understanding of the possible determinants of cervical cancer screening has
grown through studies conducted in several Latin American countries, including Argentina,
Costa Rica, Mexico, Nicaragua, and Peru. Women in the region face cultural, logistical, and
cost barriers, and their screening is limited by underdeveloped laboratory services. Limited
supply of highly trained health care providers and laboratory technicians, insufficient
evaluation and follow-up of test results, and limited availability of and access to Pap smears
all contribute to low screening and limit progress against the burden of cervical cancer (8–
14). Health care access and socioeconomic barriers may also limit overall screening
coverage and contribute to disparities among population subgroups. A woman’s ability and
decision to receive screening may depend on her knowledge about Pap smears, health care
access, socioeconomic status, and educational levels (11, 12, 15–17). Two studies in
particular—one in Nicaragua, and another in Argentina—found that health care access was
independently predictive of having had a recent Pap smear after adjusting for socioeconomic
status (12, 16). However, to the best of the authors’ knowledge, no study has examined the
effect of health care access and socioeconomic determinants in other Latin American
settings. The current study aimed to fill that gap by examining the impact of health care
access and socioeconomic determinants on Pap smear screening in diverse populations from
eight Latin American countries between 1987 and 2008. The main objective of this report is
to identify the health care and socioeconomic determinants of Pap smear knowledge and
screening. Identifying which determinants are common and which are not may help guide
pan–Latin American public health efforts.
MATERIALS AND METHODS
Data
For this cross-sectional study, socioeconomic, health care utilization, and cervical cancer
screening data collected in Demographic and Health Surveys (DHS) by the U.S. Agency for
International Development (USAID) were analyzed for women aged 21–49 years. DHS are
administered to scientifically selected samples of households and women of reproductive
age to produce nationally representative data on the population, health, and nutrition of
women and children in developing countries worldwide (18). Pertinent information used in
this study included the study data year; country; age, sex, type of residence, ethnicity,
wealth, and educational attainment of the individuals in each study sample, and whether or
not they had had a recent doctor’s visit (within the past year); Pap smear use (various criteria
by country); and knowledge of Pap smears. Ethnicity was categorized by broad, country-
specific groups, according to self-report. Wealth was analyzed based on the DHS wealth
index, which categorizes households into five quintiles according to ownership of household
items identified as indicators of relative household wealth within each country (19).
Educational attainment was divided into four groups: no education (“none”), “primary,”
“secondary,” and “higher” (post-secondary). Residence type was categorized as urban or
rural. Recent Pap smear use was analyzed for all eight countries using the following study
samples: Bolivia, n = 13 159 (2003), and n = 12 789 (2008); Brazil, n = 9 628 (1996);
Dominican Republic, n = 6 273 (1999), n = 17 719 (2002), and n = 20 410 (2007); Ecuador,
n = 3 480 (2001); Guatemala, n = 4 359 (1999); Nicaragua, n = 9 322 (2001); Peru, n = 21
800 (1996), n = 21 098 (2000), n = 4 407 (2004), n = 4 780 (2005), n = 5 181 (2006), n = 4
992 (2007), and n = 12 596 (2008); and Trinidad and Tobago, n = 2 978 (1987). The total
number of survey respondents was 174 971. Table 1 presents individuallevel characteristics
of the study population. Analysis of Pap smear knowledge was limited to Bolivia, Peru, and
Trinidad and Tobago due to lack of available data for that variable.
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Using multivariate logistic regression, the probability for both having knowledge of Pap
smears and having a recent Pap smear screening was modeled as a function of age; ethnicity;
educational attainment; type of residence; wealth quintile; recent doctor’s visit (“yes” or
“no”); and year. The results of both sets of statistical models are presented as relative risks
(20). A Pap smear was categorized as “recent” based on the standard for each country
reflected in the DHS (“in the past year” for Brazil, Dominican Republic, Guatemala,
Nicaragua, and Trinidad and Tobago; “in the past two years” for Ecuador; “in the past three
years” for Bolivia; and “in the past five years” for Peru). Separate multivariate models were
fitted for each country. For all analyses presented in this report, population projection
weights calculated by the DHS were incorporated in the data to account for the cluster
sampling design. Using the multivariate logistic regression model results, the predicted
probability of a woman receiving a recent Pap smear screening was computed as a function
of her DHS wealth index quintile, type of residence, and whether she had had a recent
doctor’s visit (21). All other covariates were set at their modal values (e.g., among Bolivian
women, age was set at 31–35 years. education was set as “primary,” and the study data year
was set as 2003). The R Project for Statistical Computing (“R”) (version 2.9.2) was used for
all statistical analyses. The Dartmouth College and Dartmouth-Hitchcock Medical Center
Committee for the Protection of Human Subjects determined that this research met
eligibility criteria for review exemption.
RESULTS
Patterns in usage and knowledge of Pap smears
Table 2 presents the proportions of women who reported having 1) a recent Pap smear
screening and 2) knowledge of Pap smears, by country and year. In all countries, the
proportion who said they had had a recent Pap smear was below 55%. For example, in the
Dominican Republic (2007) the proportion was 49% (95% CI, 49%–50%), in Bolivia (2008)
it was 42% (95% CI, 41%–43%), and in Peru (2008) it was 52% (95% CI, 51%–53%). The
proportion of women with knowledge of Pap smears grew over time in both Bolivia and
Peru, but the level of knowledge was consistently higher in the latter country.
Socieconomic determinants of Pap smear knowledge
As shown in Table 3, the key determinants of women’s knowledge of Pap smears were age,
educational attainment, and having had a recent doctor’s visit. The likelihood of knowing
about Pap smears increased with age (reaching a plateau among 31–35 year olds), and
educational attainment. For example, in Bolivia, compared to women with primary
education, women with no formal education were 19% less likely to know about Pap smears
(95% CI, 16%–22%), whereas women with secondary and higher education were 11% (95%
CI, 10%–13%) and 15% more likely (95% CI, 14%–17%) respectively. In Peru and Bolivia,
women were 4% (95% CI, 3%–5%) and 14% less likely (95% CI, 12%–17%) respectively
to know about Pap smears if they had not had a recent doctor’s visit.
Socioeconomic determinants of recent Pap smear
As shown in Table 4, the most consistent determinants of having a recent Pap smear
screening were wealth and having had a recent doctor’s visit. In Bolivia, Brazil, the
Dominican Republic, and Guatemala, a strong gradient was observed between wealth and
the probability of recent Pap smear screening. For example, in Bolivia, compared to women
in the middle wealth quintile, the probability of having had a recent Pap smear screening
was 40% lower in the poorest wealth quintile (95% CI, 34%–44%); 21% lower in the second
quintile (95% CI, 16%–26%); 12% higher in the fourth quintile (95% CI, 7%–18%); and
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29% higher in the richest quintile (95% CI, 24%–35%). No consistent wealth gradient was
observed with regard to recent Pap smear screening in Nicaragua and Peru. A recent
doctor’s visit was also a significant determinant of the probability of having a recent Pap
smear screening. Compared to women who had not had a recent doctor’s visit, the
probability of this type of screening among those who had was 48% higher in Bolivia (95%
CI, 39%–59%); 241% higher in Brazil (95% CI, 182%–312%); 98% higher in the
Dominican Republic (95% CI, 85%–113%); 77% higher in Guatemala (95% CI, 36%–
125%); and 94% higher in Nicaragua (95% CI, 67%–129%). In addition, compared to rural
residents, the probability of Pap smear screening among urban residents was higher in
Ecuador, Nicaragua, Peru, and Trinidad and Tobago. The opposite pattern was observed in
Bolivia. Disadvantaged ethnic and racial groups, especially indigenous populations, were
less likely to have received a Pap smear screening. For example, compared to Indian
(indigenous) women in Guatemala, the probability of screening was 80% higher among
Ladino women (95% CI, 46%–124%).
Figure 1 depicts the predicted probability of a recent Pap smear and simultaneously
considers the impact of wealth, type of residence, and a recent doctor’s vist. All other
covariates are set at the modal values for each country shown in Table 4. In all countries, all
women who reported a recent doctor’s visit, including rural residents, experienced
consistently higher probabilities of having a recent Pap smear screening. In addition, in
Bolivia, Brazil, the Dominican Republic, and Guatemala, women with greater wealth
experienced ever-increasing probabilities of having a recent Pap smear screening (Table 4).
This gradient was particularly high for women in Guatemala. For example, among women
with a recent doctor’s visit, the probability of having a recent Pap smear screening increased
from 16% (95% CI, 11%–23%) to 43% (95% CI, 35%–50%) to 67% (95% CI, 57%–75%)
in the poorest, middle, and richest wealth quintiles respectively.
DISCUSSION
This study has three important findings. First, the results suggest that knowledge of Pap
smears may derive indirectly from greater educational attainment. Women with greater
education may have greater awareness of and reap greater benefits from preventive
medicine, exercise greater autonomy, and face lower cultural barriers to screening (22, 23).
Second, greater accumulation of wealth increases the likelihood of having a recent Pap
smear screening. Women with greater wealth likely experience additional screening
opportunities with private practitioners, and face fewer barriers, including transportation and
household responsibilities (16, 24). Greater wealth may also enable women with a diagnosis
of cervical cancer to receive earlier treatment and regular follow-up. Third, in all Latin
American countries included in the current study, having a recent doctor’s visit was an
important determinant of the probability of having a recent Pap smear screening. Adjusting
for other socioeconomic covariates, women were between 47% and 244% more likely to
have received a recent Pap smear screening if they had had a recent doctor’s visit compared
to those who had not. In Brazil, the Dominican Republic, Nicaragua, and Peru, even the
poorest women with a recent doctor’s visit were more likely to have received a Pap smear
screening than the richest women without a recent visit. This relationship between a recent
doctor’s visit and screening may operate through several pathways. Screening may coincide
with pre- or postnatal care or treatment of an illness, as opposed to women directly seeking
preventive care (15, 17). Access to health care likely increases considerably for women with
health insurance or residing in countries with universal health insurance, as Pap smear
screening is one of many preventive health services offered under these coverage programs
(25). In addition, health care providers may disseminate Pap smear knowledge and
encourage screening, although a recent study of direct clinical observation in Peru found
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opportunities to educate patients on Pap smear screening were often missed by health care
providers (26).
Increasing Pap smear screening in Latin America may depend on two key efforts: raising
awareness of preventive care within the community, and encouraging health care providers
to advocate more effectively for this type of screening during their patients’ visits. The
effectiveness of raising awareness within the community has been demonstrated in two
recent studies. The Porque Me Quiero, Me Cuido (“Because I like my-self, I take care of
myself”) study set in Oaxaca, Mexico—one of the poorest and most rural states in Mexico—
found that women’s participation in sexual and reproductive health workshops led to
significant increases in their knowledge of and participation in Pap smear screening (24).
The Tamizaje y Tratamiento Inmediato (TATI) project set in San Martin, Peru, organized
educational events and workshops promoting cervical cancer screening. TATI also found
that women’s participation in community-based educational sessions had the greatest
influence on whether or not they received a Pap smear screening. Furthermore, women who
primarily sought care from health care providers, rather than self-treating with home-based
remedies, were more likely to undergo Pap smear screening (13, 27). Providers can have a
large influence on their patients’ health care decisions (28) and may be effective in
addressing lack of knowledge and cultural barriers, particularly embarrassment, fear of pain,
and the relationship between human papillomavirus (HPV) and cervical cancer. However, a
recent study conducted in Peru found few health care providers take advantage of this
opportunity (26).
Efficient and equitable national screening programs are necessary steps toward the larger
goal of appropriate follow-up of positive findings and early clinical treatment of cervical
cancer. Health care systems in the Dominican Republic, Guatemala, and Nicaragua are
fragmented, and access is limited to maternal health, which contribute to limited coverage of
cytology-based screening (2). Pap smear screening coverage improved throughout the
course of the current study, which took place from 1987 to 2008. For example, in Bolivia,
the 2003 Universal Maternal and Child Insurance program (Seguro Universal Materno-
Infantil, SUMI) was extended in 2006 to include cervical cancer screening for women up to
age 60 years (2). Even among countries with adequate coverage, poor quality of cytology
sampling, shortage of trained cytologists, and inadequate follow-up of positive findings
reduce the overall effectiveness of screening programs (8, 14). For example, only 25% of
women with an abnormal cytology result received appropriate follow-up care in a 2003
study in San Martin, Peru (29). In addition to limitations in health care systems, the cultural
stigma of cervical cancer and its perceived association with multiple untreated sexually
transmitted infections (STIs) may limit the effectiveness of screening (29).
This study had several limitations. First, the results are based on self-reported Pap smear
usage, which may be subject to recall and response bias. Second, three different standards
for defining a Pap smear as “recent” were used (“within one year,” “within three years,” and
“within five years”), according to the schedule of each country’s DHS. The optimal
screening interval remains an open empirical question and likely depends on previous
history of precancerous or cancerous growths, age, sexual history, and genetic and
environmental risk factors (30). Third, both recent Pap smear usage and knowledge of Pap
smears were not analyzed for all countries studied because information for the latter variable
was not included in every national DHS dataset, and the availability of data for all covariates
varied across the eight countries studied. To address this gap, separate statistical models
were estimated to incorporate as many covariates as possible for each country. Given the
limited availability of data on both recent Pap smear usage and Pap smear knowledge, it was
not possible to assess the effect of the latter variable on the likelihood of having a Pap smear
screening. Fourth, the results about usage and knowledge may not be representative within
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countries over time and across the Latin American region. Period and cohort effects may
influence Pap smear screening patterns, although not necessarily in the same direction.
Future analysis of additional DHS data and examination of age group–specific screening
rates over time would help to determine the relative importance of these two effects. In
addition, the social and health care factors identified in this study as important determinants
of recent Pap smear screening and knowledge of Pap smears may not be as salient for other
countries in Latin America. For example, Chile reoriented its cervical cancer screening
program in 1987 with an emphasis on cytology quality, followup of women screening
positive, and widespread reach across socioeconomic groups (25), resulting in a
considerable decline in the national burden of cervical cancer mortality (13 to 7 deaths per
100 000 between 1980 and 2001) (31). Fifth, it was not possible to determine the precise
causal nature that underlies the relationship between a recent doctor’s visit and screening
and the timing of these events. Further research on discussions between patients and doctors
would help disentangle this potentially endogenous relationship, especially if coupled with
knowledge of the nature and purpose of the doctor’s visit (e.g., prenatal care). The problem
of endogeneity is a common concern in epidemiologic studies that utilize cross-sectional
data (32–34). The covariates included in this study’s statistical model, such as wealth
quintile and recent doctor’s visit, may be correlated with other excluded variables that may
also determine whether a woman was recently screened through a Pap smear. Statistical
methods such as instrumental variable (IV) estimation could prove useful if the IV is
strongly correlated with the potentially endogenous variables and is truly exogenous to the
model. Large cross-national studies such as this one reveal broad patterns between
socioeconomic determinants and health. More focused quasi-experimental and experimental
studies, coordinated throughout Latin America, could reveal how these and other
determinants produce health and perpetuate health disparities.
Reducing the overall burden of cervical cancer and narrowing historical disparities are two
paramount public health goals in cervical cancer. How to optimally achieve these goals
remains an open question, especially in resource-limited settings. Pre- and perinatal care
visits may represent two important and currently underutilized opportunities for health care
providers to educate their patients about Pap smears. However, increasing the availability
and accessibility of Pap smears may provide no additional benefit if pathology services
remain underdeveloped, and follow-up of positive screenings remain low. Other techniques,
such as simple visual inspection, visual inspection with acetic acid, or HPV DNA testing,
may prove as or more effective (35, 36). In addition, increased screening efforts may result
in decreased resources for treatment and HPV vaccination (37). As new screening
modalities, vaccinations, and treatments become available, the focus of strategies to reduce
cervical cancer may shift away from Pap smears. However, the socioeconomic determinants
identified in the current study may continue to perpetuate disparities unless directly
addressed by antipoverty and education programs.
In conclusion, this study found several socioeconomic and health care factors that are
important determinants of Pap smear knowledge and screening across eight countries in
Latin America. Efforts to reduce poverty through education may increase Pap smear
knowledge and use, and efforts to increase access to health care providers may be just as
important as greater wealth accumulation.
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Predicted probability of recenta Pap smear, by country, wealth quintile, type of residence,
and recentb doctor visit (yes or no), based on Demographic and Health Survey (DHS) data
from six Latin American countries, 1999–2008c
a In past year (Brazil, Dominican Republic, Guatemala, and Nicaragua); in past three years
(Bolivia); in past five years (Peru).
b In past year (all countries).
c Shading indicates 95% confidence intervals for each category.
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TABLE 1
Demographic and health care characteristics of sample population for study on socioeconomic determinants of




















n 2 978 4 359 9 628 44 402 9 322 3 480 25 948 53 054
Age group (years)
 21–25 600 (20) 872 (20) 1 544 (16) 7 847 (18) 1 810 (19) 728 (21) 4 704 (18) 8 847 (17)
 26–30 745 (25) 935 (21) 1 955 (20) 8 811 (20) 2 021 (22) 834 (24) 5 412 (21) 10 310 (19)
 31–35 543 (18) 785 (18) 1 869 (19) 8 193 (18) 1 650 (18) 664 (19) 4 799 (18) 9 943 (19)
 36–40 441 (15) 710 (16) 1 713 (18) 7 679 (17) 1 596 (17) 567 (16) 4 288 (17) 9 136 (17)
 41–45 370 (12) 550 (13) 1 400 (15) 6 495 (15) 1 217 (13) 396 (11) 3 664 (14) 8 112 (15)
 46–49 279 (9) 507 (12) 1 147 (12) 5 377 (12) 1 028 (11) 291 (8) 3 081 (12) 6 706 (13)
Education
 None 29 (1) 1 597 (37) 71 9 (7) 3 017 (7) 1 941 (21) 328 (9) 1 822 (7) 3 268 (6)
 Primary 1 606 (54) 2 080 (48) 3 462 (36) 20 881 (47) 3 909 (42) 1 746 (50) 12 184 (47) 18 152 (34)
 Secondary 1 270 (43) 589 (14) 4 747 (49) 12 596 (28) 2 532 (27) 1 010 (29) 6 909 (27) 17 674 (33)
 Higherd 72 (2) 93 (2) 698 (7) 7 906 (18) 940 (10) 396 (11) 5 033 (19) 13 960 (26)
Residence type
 Urban 1 350 (45) 1 443 (33) 7 844 (81) 27 187 (61) 5 261 (56) 2 057 (59) 16 750 (65) 33 163 (63)
 Rural 1 628 (55) 2 916 (67) 1 784 (19) 17 215 (39) 4 061 (44) 1 423 (41) 9 198 (35) 19 891 (37)
Wealth quintilee
 Poorest f 1 188 (27) 1 925 (20) 10 163 (23) 1 801 (19) f 4 265 (16) 11 388 (21)
 Poorer f 914 (21) 2 146 (22) 9 721 (22) 1 794 (19) f 4 654 (18) 11 149 (21)
 Middle f 905 (21) 1 993 (21) 8 972 (20) 1 603 (17) f 5 247 (20) 7 996 (15)
 Richer f 789 (18) 1 866 (19) 8 003 (18) 1 548 (17) f 5 773 (22) 10 678 (20)
 Richest f 563 (13) 1 698 (18) 6 379 (14) 1 343 (14) f 6 009 (23) 9 787 (18)
Saw doctor within past
year
 No f 3 018 (69) 3 709 (39) 13 051 (29) 4 236 (45) f 10 186 (39) 30 115 (57)
 Yes f 1 335 (31) 5 916 (61) 31 293 (70) 5 085 (55) f 15 752 (61) 22 936 (43)
Ethnicityg
 African 1 049 (35) _h – f f f f –
 Black – – 363 (4) f f f f –
 East Asian – – 40 (0) f f f f –
 East Indian 1 417 (48) – – f f f f –
 Indian (indigenous) – 1 614 (37) 3 (0) f f f f –
 Ladino – 2 745 (63) – f f f f –
 Mixed 487 (16) – 5 552 (58) f f f f –
 Other 24 (1) – – f f f f 500 (1)
 Quechua/Aymara – – – f f f f 6 410 (12)
 Spanish – – – f f f f 46 134 (87)

































 White – – 3 666 (38) f f f f –
a
Source: Demographic and Health Surveys (DHS).
b
Sample sizes vary slightly by subgroup due to missing data; percentages may not sum to 100 due to rounding.
c




Based on DHS wealth index, which categorizes households into five quintiles according to ownership of household items identified as indicators
of relative household wealth within each country.
f
Data not available for this variable.
g
Self-reported, based on broad, country-specific ethnic groups.
h
Not applicable.













Soneji and Fukui Page 12
TABLE 2
Proportion of women who reported recent Pap smear usage and knowledge of Pap smears in eight Latin
American countries, 1987–2008a
Had recent Pap smear Knew about Pap smears
Country Year n Time frame % 95% CIb % 95% CI
Trinidad and Tobago 1987 2 978 Past year 10.4 9.3–11.5 57.5 55.7–59.2
Brazil 1996 9 628 Past year 38.1 37.1–39.1 c c
Guatemala 1999 4 359 Past year 26.5 25.2–27.9 c c
Dominican Republic 1999 6 273 Past year 34.5 33.3–35.7 c c
2002 17 719 45.1 44.4–45.8 c c
2007 20 410 49.4 48.7–50.1 c c
Nicaragua 2001 9 322 Past year 35.8 34.9–36.8 c c
Ecuador 2001 3 480 Past two years 28.7 27.2–30.2 c c
Bolivia 2003 13 159 Past three years 36.0 35.2–36.9 66.9 66.1–67.7
2008 12 789 42.3 41.4–43.1 74.0 73.3–74.8
Peru 1996 21 800 Past five years 43.3 42.6–43.9 83.1 82.6–83.6
2000 21 098 49.1 48.5–49.8 89.3 88.9–89.8
2004 4 407 51.5 50.0–53.0 91.9 91.1–92.7
2005 4 780 49.9 48.5–51.4 93.7 93.0–94.4
2006 5 181 49.4 48.0–50.8 93.1 92.4–93.8
2007 4 992 48.9 47.5–50.3 93.8 93.1–94.5
2008 12 596 52.1 51.2–53.0 93.9 93.5–94.3
a




Data not available for this variable.
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TABLE 3
Relative risks of having knowledge about Pap smears, according to multivariate logistic regression modeling
using demographic and health care data from three Latin American countries, 1987–2008a
Trinidad and Tobago Bolivia Peru
Characteristic RRb 95% CIc RR 95% CI RR 95% CI
Age group (years)
 21–25 0.52 0.44–0.62 0.76 0.73–0.78 0.95 0.94–0.96
 26–30 0.82 0.72–0.92 0.94 0.92–0.96 0.99 0.98–0.99
 31–35d 1 – e 1 – 1 –
 36–40 1.07 0.94–1.21 1.00 0.98–1.02 1.01 1.00–1.01
 41–45 1.02 0.89–1.16 1.01 0.99–1.03 1.01 1.00–1.01
 46–49 0.97 0.84–1.13 0.99 0.97–1.01 1.01 1.00–1.01
Education
 None 0.35 0.13–0.74 0.81 0.78–0.84 0.94 0.93–0.96
 Primaryd 1 – 1 – 1 –
 Secondary 1.48 1.38–1.62 1.11 1.10–1.13 1.02 1.02–1.03
 Higherf 1.74 1.55–1.95 1.15 1.14–1.17 1.03 1.03–1.04
Residence type
 Urband 1 – 1 – 1 –
 Rural 0.76 0.70–0.83 0.97 0.95–0.98 0.94 0.93–0.95
Wealth quintileg
 Poorest h – 0.77 0.73–0.80 1.01 1.00–1.01
 Poorer h – 0.91 0.89–0.94 1.01 1.01–1.02
 Middled h – 1 – 1 –
 Richer h – 1.07 1.05–1.09 1.02 1.01–1.03
 Richest h – 1.10 1.07–1.12 1.02 1.01–1.03
Saw doctor within past
year
 Nod h – 1 – 1 –
 Yes h – 0.86 0.83–0.88 0.96 0.95–0.97
Yeari
 2000 h – h – 0.96 0.95–0.97
 2003 h – 1d – h –
 2004 h – h – 1.00 0.99–1.01
 2005 h – h – 1.02 1.01–1.03
 2006 h – h – 1.01 1–1.02
 2007 h – h – 1.01 1–1.02
 2008 h – 1.08 1.07–1.10 1d –
Ethnicityj
 African 1d – h – – –
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Trinidad and Tobago Bolivia Peru
Characteristic RRb 95% CIc RR 95% CI RR 95% CI
 East Indian 0.85 0.78–0.92 h – – –
 Mixed 1.06 0.98–1.15 h – – –
 Other 1.12 0.69–1.43 h – 0.89 0.84–0.92
 Quechua/Aymara – – h – 0.86 0.84–0.88
 Spanish – – h – 1d –
a












Based on the DHS wealth index, which categorizes households into 5 quintiles according to ownership of household items identified as indicators
of relative household wealth within each country.
h
Data not available for this variable.
i
Data for Trinidad and Tobago were only available for a single year (1987), so the covariate “year” was not included in the Trinidad and Tobago
model. Data for Peru did not include 1996 values because survey respondent race/ethnicity was not ascertained for that year.
j
Self-reported, based on broad, country-specific ethnic groups.
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